WO2007079189A3 - System and method for remote based control of an iontophoresis device - Google Patents

System and method for remote based control of an iontophoresis device Download PDF

Info

Publication number
WO2007079189A3
WO2007079189A3 PCT/US2006/049498 US2006049498W WO2007079189A3 WO 2007079189 A3 WO2007079189 A3 WO 2007079189A3 US 2006049498 W US2006049498 W US 2006049498W WO 2007079189 A3 WO2007079189 A3 WO 2007079189A3
Authority
WO
WIPO (PCT)
Prior art keywords
iontophoresis
active agent
iontophoresis devices
iontophoresis device
invention comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/049498
Other languages
French (fr)
Other versions
WO2007079189A2 (en
Inventor
Darrick Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transcutaneous Tech Inc
Original Assignee
Transcutaneous Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transcutaneous Tech Inc filed Critical Transcutaneous Tech Inc
Priority to EP06848286A priority Critical patent/EP1965858A2/en
Publication of WO2007079189A2 publication Critical patent/WO2007079189A2/en
Publication of WO2007079189A3 publication Critical patent/WO2007079189A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L9/00—Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols
    • H04L9/32—Cryptographic mechanisms or cryptographic arrangements for secret or secure communications; Network security protocols including means for verifying the identity or authority of a user of the system or for message authentication, e.g. authorization, entity authentication, data integrity or data verification, non-repudiation, key authentication or verification of credentials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0444—Membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L2209/00—Additional information or applications relating to cryptographic mechanisms or cryptographic arrangements for secret or secure communication H04L9/00
    • H04L2209/88—Medical equipments
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L63/00—Network architectures or network communication protocols for network security
    • H04L63/04—Network architectures or network communication protocols for network security for providing a confidential data exchange among entities communicating through data packet networks
    • H04L63/0428—Network architectures or network communication protocols for network security for providing a confidential data exchange among entities communicating through data packet networks wherein the data content is protected, e.g. by encrypting or encapsulating the payload
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L63/00—Network architectures or network communication protocols for network security
    • H04L63/10—Network architectures or network communication protocols for network security for controlling access to devices or network resources

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Computer Security & Cryptography (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Electrotherapy Devices (AREA)

Abstract

The present invention comprises an active agent reservoir that stores a quantity of an active agent, an active electrode element operable to apply an electrical potential of a first polarity to deliver at least a portion of the active agent to a biological interface from the iontophoresis device, and a communications port providing a communications path between the iontophoresis device and a remote device. A method of the invention comprises operating an interface system to remotely interact with iontophoresis devices useful in delivery of active agents to biological interfaces including providing a user interface at a location remote from at least some of the iontophoresis devices, communicating with at least two of the iontophoresis devices, and providing information about the iontophoresis devices via the user interface.
PCT/US2006/049498 2005-12-30 2006-12-12 System and method for remote based control of an iontophoresis device Ceased WO2007079189A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06848286A EP1965858A2 (en) 2005-12-30 2006-12-12 System and method for remote based control of an iontophoresis device

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75525005P 2005-12-30 2005-12-30
US60/755,250 2005-12-30

Publications (2)

Publication Number Publication Date
WO2007079189A2 WO2007079189A2 (en) 2007-07-12
WO2007079189A3 true WO2007079189A3 (en) 2007-09-27

Family

ID=38228857

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/049498 Ceased WO2007079189A2 (en) 2005-12-30 2006-12-12 System and method for remote based control of an iontophoresis device

Country Status (3)

Country Link
US (1) US20070213652A1 (en)
EP (1) EP1965858A2 (en)
WO (1) WO2007079189A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4728631B2 (en) * 2004-11-30 2011-07-20 Ｔｔｉ・エルビュー株式会社 Iontophoresis device
US7590444B2 (en) * 2004-12-09 2009-09-15 Tti Ellebeau, Inc. Iontophoresis device
JP4731931B2 (en) 2005-02-03 2011-07-27 Ｔｔｉ・エルビュー株式会社 Iontophoresis device
JP4793806B2 (en) * 2005-03-22 2011-10-12 Ｔｔｉ・エルビュー株式会社 Iontophoresis device
US8295922B2 (en) 2005-08-08 2012-10-23 Tti Ellebeau, Inc. Iontophoresis device
US8386030B2 (en) 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US20070088331A1 (en) * 2005-08-18 2007-04-19 Transcutaneous Technologies Inc. Method and apparatus for managing active agent usage, and active agent injecting device
US20070060860A1 (en) * 2005-08-18 2007-03-15 Transcutaneous Technologies Inc. Iontophoresis device
KR20080047600A (en) 2005-09-15 2008-05-29 티티아이 엘뷰 가부시키가이샤 Rod type iontophoresis device
JP2009542685A (en) * 2006-07-05 2009-12-03 Ｔｔｉ・エルビュー株式会社 Delivery device having self-organizing resinous polymer and method of use thereof
US20080077076A1 (en) * 2006-08-29 2008-03-27 Transcutaneous Technologies Inc. Iontophoresis device and method for operation with a usb (universal serial bus) power source
KR20090106492A (en) 2006-12-01 2009-10-09 티티아이 엘뷰 가부시키가이샤 Systems, devices, and methods for providing or controlling power to devices such as transdermal delivery devices
CA2708497A1 (en) * 2007-12-10 2009-06-18 Isis Biopolymer Llc Iontophoretic drug delivery device and software application
US8072098B2 (en) * 2008-09-29 2011-12-06 Honeywell International Inc. Remotely configurable analog/digital input circuit and related apparatus and method
JP5432625B2 (en) * 2009-07-29 2014-03-05 株式会社トプコン Ophthalmic observation device
WO2011077252A2 (en) 2009-12-23 2011-06-30 Nuformix Limited Metaxalone cocrystals
JP2015534862A (en) * 2012-11-14 2015-12-07 インターナショナル・サイエンティフィック・プロプライエタリー・リミテッド Apparatus, system, method, computer program, and data signal for controlling a transdermal delivery device
JPWO2014115183A1 (en) * 2013-01-23 2017-01-19 テルモ株式会社 Drug administration device and method of operating the same
WO2014125518A1 (en) * 2013-02-18 2014-08-21 テルモ株式会社 Medicine administering device, medicine administering system, and control method for same
US10825263B2 (en) 2016-06-16 2020-11-03 Honeywell International Inc. Advanced discrete control device diagnostic on digital output modules
WO2020010388A1 (en) * 2018-07-13 2020-01-16 International Scientific Pty Ltd A method and apparatus for user-controlled or practitioner-prescribed transdermal, intradermal or transappendageal delivery of therapeutic, cosmetic or skin care ingredients
CN109364373B (en) * 2018-12-24 2022-11-11 李新虹 Facial paralysis recovery nursing device based on penetration therapy
JP7633176B2 (en) * 2019-03-31 2025-02-19 レズメド インコーポレイテッド Method and system for analyzing one or more analytes from a user - Patents.com
JP2023123177A (en) * 2022-02-24 2023-09-05 セイコーエプソン株式会社 Electronic device and method of processing electronic device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030208152A1 (en) * 1998-11-09 2003-11-06 Zohar Avrahami Electronic card for transdermal drug delivery and analyte extraction
US20050203582A1 (en) * 2004-03-15 2005-09-15 Healy Scott J. Cryptographic authentication for telemetry with an implantable medical device

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2626294C3 (en) * 1976-06-11 1980-01-10 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantable dosing device
JPS59502026A (en) * 1982-11-17 1984-12-06 シエブロン　リサ−チ　コンパニ− electroactive polymer
US5224928A (en) * 1983-08-18 1993-07-06 Drug Delivery Systems Inc. Mounting system for transdermal drug applicator
US4585652A (en) * 1984-11-19 1986-04-29 Regents Of The University Of Minnesota Electrochemical controlled release drug delivery system
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
US4915685A (en) * 1986-03-19 1990-04-10 Petelenz Tomasz J Methods and apparatus for iontophoresis application of medicaments at a controlled ph through ion exchange
US4725263A (en) * 1986-07-31 1988-02-16 Medtronic, Inc. Programmable constant current source transdermal drug delivery system
US4731049A (en) * 1987-01-30 1988-03-15 Ionics, Incorporated Cell for electrically controlled transdermal drug delivery
US4940456A (en) * 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4931046A (en) * 1987-05-15 1990-06-05 Newman Martin H Iontophoresis drug delivery system
US4927408A (en) * 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
US5496266A (en) * 1990-04-30 1996-03-05 Alza Corporation Device and method of iontophoretic drug delivery
DE69011251T2 (en) * 1989-09-12 1995-03-23 Hiroshi Hukuba Toothbrush with voltage tester.
US4950229A (en) * 1989-09-25 1990-08-21 Becton, Dickinson And Company Apparatus for an electrode used for iontophoresis
US5320597A (en) * 1991-02-08 1994-06-14 Becton, Dickinson And Company Device and method for renewing electrodes during iontophoresis
US5084008A (en) * 1989-12-22 1992-01-28 Medtronic, Inc. Iontophoresis electrode
DK0522043T3 (en) * 1990-03-30 2004-02-23 Alza Corp Iontophoretic administration device
US5224927A (en) * 1990-11-01 1993-07-06 Robert Tapper Iontophoretic treatment system
GB2265088B (en) * 1992-03-10 1996-02-07 Kyosti Eero Antero Kontturi Electrochemical device for drug delivery
US5405614A (en) * 1992-04-08 1995-04-11 International Medical Associates, Inc. Electronic transdermal drug delivery system
US5312326A (en) * 1992-06-02 1994-05-17 Alza Corporation Iontophoretic drug delivery apparatus
ATE159179T1 (en) * 1992-06-02 1997-11-15 Alza Corp DEVICE FOR IONTOPHORETIC ADMINISTRATION OF MEDICATIONS
US5380271A (en) * 1992-09-24 1995-01-10 Alza Corporation Electrotransport agent delivery device and method
US5306235A (en) * 1992-09-30 1994-04-26 Becton Dickinson And Company Failsafe iontophoresis drug delivery system
US5322520A (en) * 1992-11-12 1994-06-21 Implemed, Inc. Iontophoretic structure for medical devices
AU2286995A (en) * 1994-04-08 1995-10-30 Alza Corporation Electrotransport system with ion exchange competitive ion capture
US5503632A (en) * 1994-04-08 1996-04-02 Alza Corporation Electrotransport device having improved cathodic electrode assembly
US20030088205A1 (en) * 1994-09-07 2003-05-08 Chandrasekaran Santosh Kumar Electrotransport delivery of leuprolide
IE960312A1 (en) * 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
EP0748636B1 (en) * 1995-06-14 2003-08-27 Hisamitsu Pharmaceutical Co., Inc. Interface for iontophoresis
US6167301A (en) * 1995-08-29 2000-12-26 Flower; Ronald J. Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit
US5733269A (en) * 1996-03-15 1998-03-31 Fuisz Technologies Ltd. Method and kit for positioning transdermal delivery system
US5738647A (en) * 1996-09-27 1998-04-14 Becton Dickinson And Company User activated iontophoretic device and method for activating same
FR2755372B1 (en) * 1996-11-07 1998-12-24 Elf Aquitaine IONOPHORESIS DEVICE COMPRISING AT LEAST ONE MEMBRANE ELECTRODE ASSEMBLY FOR THE TRANSCUTANEOUS ADMINISTRATION OF ACTIVE PRINCIPLES TO A SUBJECT
FR2755842B1 (en) * 1996-11-19 1999-04-23 Lhd Lab Hygiene Dietetique METHOD FOR MEASURING THE SKIN RESISTANCE OF A PATIENT SUBJECT TO A TRANSDERMAL ADMINISTRATION OF MEDICAMENT
DE19717023C2 (en) * 1997-04-23 2003-02-06 Micronas Gmbh Device for treating malignant, tumorous tissue areas
JP4079481B2 (en) * 1997-06-27 2008-04-23 久光製薬株式会社 Device for transdermal or transmucosal drug delivery
US6228206B1 (en) * 1997-07-30 2001-05-08 Drug Delivery Technologies, Inc. Bonding agent composition containing conductive filler and method of bonding electrode to printed conductive trace with same
US6047208A (en) * 1997-08-27 2000-04-04 Becton, Dickinson And Company Iontophoretic controller
US6178353B1 (en) * 1998-07-27 2001-01-23 Advanced Bionics Corporation Laminated magnet keeper for implant device
US6532386B2 (en) * 1998-08-31 2003-03-11 Johnson & Johnson Consumer Companies, Inc. Electrotransort device comprising blades
TW429382B (en) * 1998-11-06 2001-04-11 Matsushita Electric Industrial Co Ltd Regulating resistor, semiconductor equipment and its production method
US6405875B1 (en) * 1998-12-18 2002-06-18 Corning Incorporated Water filtration device and method
US6855441B1 (en) * 1999-04-14 2005-02-15 Power Paper Ltd. Functionally improved battery and method of making same
JP4180244B2 (en) * 1999-04-16 2008-11-12 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド Electrical transfer system with internal sensor
US6385488B1 (en) * 1999-05-20 2002-05-07 Vyteris, Inc. Circuits for increasing the reliability of an iontophoretic system
DK1189660T3 (en) * 1999-06-08 2006-08-21 Altea Therapeutics Corp Apparatus for microperforating biological membranes by thin-film-tissue interface devices and method for making them
US6377848B1 (en) * 1999-08-25 2002-04-23 Vyteris, Inc. Devices activating an iontophoretic delivery device
US6394994B1 (en) * 1999-08-27 2002-05-28 Vyteris, Inc. Method for testing the ability of an iontophoretic reservoir-electrode to deliver a medicament
US6368275B1 (en) * 1999-10-07 2002-04-09 Acuson Corporation Method and apparatus for diagnostic medical information gathering, hyperthermia treatment, or directed gene therapy
US6539250B1 (en) * 1999-12-15 2003-03-25 David S. Bettinger Programmable transdermal therapeutic apparatus
US7533747B2 (en) * 2000-01-26 2009-05-19 E-Traction Europe B.V. Wheel provided with driving means
US7141034B2 (en) * 2000-06-08 2006-11-28 Altea Therapeutics Corporation Transdermal drug delivery device, method of making same and method of using same
AU2001283357A1 (en) * 2000-08-14 2002-02-25 Pharmacia Corporation Drug delivery system with bilayer electrodes
US6844028B2 (en) * 2001-06-26 2005-01-18 Accelr8 Technology Corporation Functional surface coating
US7247370B2 (en) * 2001-07-20 2007-07-24 Mcmaster University Asymmetric gel-filled microporous membranes
US6723077B2 (en) * 2001-09-28 2004-04-20 Hewlett-Packard Development Company, L.P. Cutaneous administration system
EE200400090A (en) * 2001-10-31 2004-10-15 R&R Ventures Incorporation Ionophoresis device
US6708050B2 (en) * 2002-03-28 2004-03-16 3M Innovative Properties Company Wireless electrode having activatable power cell
US20060009730A2 (en) * 2002-07-29 2006-01-12 Eemso, Inc. Iontophoretic Transdermal Delivery of One or More Therapeutic Agents
US6994933B1 (en) * 2002-09-16 2006-02-07 Oak Ridge Micro-Energy, Inc. Long life thin film battery and method therefor
GB2393860B (en) * 2002-09-27 2006-02-15 Zap Wireless Technologies Ltd Improvements relating to retention of rechargeable devices
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
US8734421B2 (en) * 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US20050113744A1 (en) * 2003-11-21 2005-05-26 Cyberkinetics, Inc. Agent delivery systems and related methods under control of biological electrical signals
US20060083962A1 (en) * 2004-10-20 2006-04-20 Nissan Motor Co., Ltd. Proton-conductive composite electrolyte membrane and producing method thereof
US20060095001A1 (en) * 2004-10-29 2006-05-04 Transcutaneous Technologies Inc. Electrode and iontophoresis device
US20060135906A1 (en) * 2004-11-16 2006-06-22 Akihiko Matsumura Iontophoretic device and method for administering immune response-enhancing agents and compositions
JP4728631B2 (en) * 2004-11-30 2011-07-20 Ｔｔｉ・エルビュー株式会社 Iontophoresis device
US7590444B2 (en) * 2004-12-09 2009-09-15 Tti Ellebeau, Inc. Iontophoresis device
JP2006346368A (en) * 2005-06-20 2006-12-28 Transcutaneous Technologies Inc Iontophoresis apparatus and manufacturing method
JP2007000342A (en) * 2005-06-23 2007-01-11 Transcutaneous Technologies Inc Iontophoresis device for controlling quantity and time of dosing a plurality of medicaments
US20070027426A1 (en) * 2005-06-24 2007-02-01 Transcutaneous Technologies Inc. Iontophoresis device to deliver active agents to biological interfaces
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
US8295922B2 (en) * 2005-08-08 2012-10-23 Tti Ellebeau, Inc. Iontophoresis device
US20070088331A1 (en) * 2005-08-18 2007-04-19 Transcutaneous Technologies Inc. Method and apparatus for managing active agent usage, and active agent injecting device
US20070060860A1 (en) * 2005-08-18 2007-03-15 Transcutaneous Technologies Inc. Iontophoresis device
US20070088332A1 (en) * 2005-08-22 2007-04-19 Transcutaneous Technologies Inc. Iontophoresis device
US20070112294A1 (en) * 2005-09-14 2007-05-17 Transcutaneous Technologies Inc. Iontophoresis device
KR20080047600A (en) * 2005-09-15 2008-05-29 티티아이 엘뷰 가부시키가이샤 Rod type iontophoresis device
US20070073212A1 (en) * 2005-09-28 2007-03-29 Takehiko Matsumura Iontophoresis apparatus and method to deliver active agents to biological interfaces
US20070071807A1 (en) * 2005-09-28 2007-03-29 Hidero Akiyama Capsule-type drug-releasing device and capsule-type drug-releasing device system
US20070078445A1 (en) * 2005-09-30 2007-04-05 Curt Malloy Synchronization apparatus and method for iontophoresis device to deliver active agents to biological interfaces
US20070135754A1 (en) * 2005-09-30 2007-06-14 Hidero Akiyama Electrode assembly for iontophoresis for administering active agent enclosed in nanoparticle and iontophoresis device using the same
US20070078375A1 (en) * 2005-09-30 2007-04-05 Transcutaneous Technologies Inc. Iontophoretic delivery of active agents conjugated to nanoparticles
AU2006299520A1 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoresis device to deliver multiple active agents to biological interfaces
EP1928542A1 (en) * 2005-09-30 2008-06-11 Tti Ellebeau, Inc. Method and system to detect malfunctions in an iontophoresis device that delivers active agents to biological interfaces
US20070078376A1 (en) * 2005-09-30 2007-04-05 Smith Gregory A Functionalized microneedles transdermal drug delivery systems, devices, and methods
BRPI0616487A2 (en) * 2005-09-30 2011-06-21 Tti Ellebeau Inc apparatus and method of iontophoresis for systemic release of active agents
JP2009542685A (en) * 2006-07-05 2009-12-03 Ｔｔｉ・エルビュー株式会社 Delivery device having self-organizing resinous polymer and method of use thereof
US20080077076A1 (en) * 2006-08-29 2008-03-27 Transcutaneous Technologies Inc. Iontophoresis device and method for operation with a usb (universal serial bus) power source
CN101528300A (en) * 2006-09-05 2009-09-09 Tti优而美株式会社 Transdermal drug delivery systems, devices, and methods using inductive power supplies
KR20090106492A (en) * 2006-12-01 2009-10-09 티티아이 엘뷰 가부시키가이샤 Systems, devices, and methods for providing or controlling power to devices such as transdermal delivery devices

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030208152A1 (en) * 1998-11-09 2003-11-06 Zohar Avrahami Electronic card for transdermal drug delivery and analyte extraction
US20050203582A1 (en) * 2004-03-15 2005-09-15 Healy Scott J. Cryptographic authentication for telemetry with an implantable medical device

Also Published As

Publication number Publication date
WO2007079189A2 (en) 2007-07-12
EP1965858A2 (en) 2008-09-10
US20070213652A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
WO2007079189A3 (en) System and method for remote based control of an iontophoresis device
WO2008028063A3 (en) Electrode assembly and method of using same
WO2007041322A3 (en) Iontophoretic delivery of active agents conjugated to nanoparticles
WO2006110913A3 (en) Devices and methods for use in assessing a flow condition of a fluid
WO2007079193A3 (en) Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
WO2004073765A8 (en) Drug delivery device and syringe for filling the same
WO2007021894A3 (en) Controller device for an infusion pump
DK1924307T3 (en) Handheld controller for an infusion pump
AU2003215064A1 (en) Autonomous, ambulatory analyte monitor or drug delivery device
EP2316505A3 (en) Mems device for delivery of therapeutic agents
WO2006004735A3 (en) Control system for electrical devices
MX2007009668A (en) Ehd aerosol dispensing device and spraying method.
WO2003099458A3 (en) Low leakage piezoelectric atomization device
WO2007041001A3 (en) Synchronization apparatus and method for iontophoresis device to deliver active agents to biological interfaces
WO2008078318A3 (en) Systems and devices for sustained delivery of therapeutic fluid
EP1471953A4 (en) Gas pressure actuated microneedle arrays, and systems and methods relating to same
WO2007041314A3 (en) Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
WO2005070134A3 (en) Iontophoretic devices and methods
WO2007041300A3 (en) Iontophoresis method and apparatus for systemic delivery of active agents
WO2007065044A3 (en) Communication system for medical devices
WO2008038241A3 (en) Electrically activated gel array for transdermal drug delivery
PL1543851T3 (en) Implantable active agent delivery device
WO2007149514A3 (en) Methods, devices, and kits for microjet drug delivery
AU2003223680A1 (en) Transcutaneous fluid delivery system
WO2010009382A3 (en) Analyte measurement and management device and associated methods

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2006848286

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06848286

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE